Fingerprint
Dive into the research topics of 'Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically